References
Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet 2019, 393: 689–701.
Collaborators G2E. Global, regional, and national burden of epilepsy, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019, 18: 357–375.
de Lanerolle NC, Kim JH, Williamson A, Spencer SS, Zaveri HP, Eid T. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: Evidence for distinctive patient subcategories. Epilepsia 2003, 44: 677–687.
Kobayashi M, Buckmaster PS. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 2003, 23: 2440–2452.
Hu JS, Vogt D, Sandberg M, Rubenstein JL. Cortical interneuron development: A tale of time and space. Development 2017, 144: 3867–3878.
Casalia ML, Howard MA, Baraban SC. Persistent seizure control in epileptic mice transplanted with gamma-aminobutyric acid progenitors. Ann Neurol 2017, 82: 530–542.
Bershteyn M, Bröer S, Parekh M, Maury Y, Havlicek S, Kriks S, et al. Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy. Cell Stem Cell 2023, 30: 1331-1350.e11.
Upadhya D, Hattiangady B, Castro OW, Shuai B, Kodali M, Attaluri S, et al. Human induced pluripotent stem cell-derived MGE cell grafting after status epilepticus attenuates chronic epilepsy and comorbidities via synaptic integration. Proc Natl Acad Sci U S A 2019, 116: 287–296.
Cunningham M, Cho JH, Leung A, Savvidis G, Ahn S, Moon M, et al. hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice. Cell Stem Cell 2014, 15: 559–573.
Zhu Q, Mishra A, Park JS, Liu D, Le DT, Gonzalez SZ, et al. Human cortical interneurons optimized for grafting specifically integrate, abort seizures, and display prolonged efficacy without over-inhibition. Neuron 2023, 111: 807-823.e7.
Baraban SC, Southwell DG, Estrada RC, Jones DL, Sebe JY, Alfaro-Cervello C, et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc Natl Acad Sci U S A 2009, 106: 5472–15477.
Acknowledgements
This research highlight was supported by grants from the National Natural Science Foundation (82204350) and the Natural Science Foundation of Zhejiang Province (Q22H309365 and LQ22H310007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflict of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, J., Li, Z., Wang, Y. et al. GABAergic Interneuron Cell Therapy for Drug-Resistant Epilepsy. Neurosci. Bull. (2024). https://doi.org/10.1007/s12264-024-01195-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12264-024-01195-1